M Pharmaceutical Inc. (DB:T3F1) intends to pursue acquisitions. The Company is undertaking a non-brokered private placement of up to $0.75 million. First Sahara intends to use the proceeds for general working capital, including the review of possible acquisitions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
2018 | James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc | CI |
2018 | Callitas Health Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.53T | |
+55.55% | 5.93TCr | |
+43.74% | 4.09TCr | |
-4.71% | 4.02TCr | |
-5.56% | 2.87TCr | |
+13.76% | 2.66TCr | |
-22.00% | 1.89TCr | |
+31.50% | 1.25TCr | |
+2.16% | 1.24TCr | |
+25.70% | 1.23TCr |
- Stock Market
- Equities
- MPHMF Stock
- News Callitas Health Inc.
- First Sahara Mulls Acquisitions